Related references
Note: Only part of the references are listed.Targeting breast cancer through its microenvironment: Current status of preclinical and clinical research in finding relevant targets
H. H. Nienhuis et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Placental growth factor in cancer
Mieke Dewerchin et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Anti-Vascular Endothelial Growth Factor Therapy in Breast Cancer
Tina Bogelund Kristensen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients
Brigitte Rack et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Expression of the sFLT1 Gene in Cord Blood Cells Is Associated to Maternal Arsenic Exposure and Decreased Birth Weight
Sylvie Remy et al.
PLOS ONE (2014)
Depression, cytokines, and pancreatic cancer
William Breitbart et al.
PSYCHO-ONCOLOGY (2014)
Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer
S. Mitsunaga et al.
BRITISH JOURNAL OF CANCER (2013)
Combining virotherapy and angiotherapy for the treatment of breast cancer
M. Bazan-Peregrino et al.
CANCER GENE THERAPY (2013)
Biomarkers for Anti-Angiogenic Therapy in Cancer
Markus Wehland et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases
Masabumi Shibuya
JOURNAL OF BIOCHEMISTRY (2013)
Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs
Eva-Maria Eleonora Hedlund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Delivery of Soluble VEGF Receptor 1 (sFlt1) by Gene Electrotransfer as a New Antiangiogenic Cancer Therapy
Julien Verrax et al.
MOLECULAR PHARMACEUTICS (2011)
Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer
Edoardo Botteri et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Blood outgrowth endothelial cell-based systemic delivery of antiangiogenic gene therapy for solid tumors
V. Bodempudi et al.
CANCER GENE THERAPY (2010)
Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease
Sara Van de Veire et al.
CELL (2010)
Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Gang Niu et al.
CURRENT DRUG TARGETS (2010)
Different Responsiveness of Endothelial Cells to Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Added to Culture Media Under Gravity and Simulated Microgravity
Daniela Grimm et al.
TISSUE ENGINEERING PART A (2010)
Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer
A. Daskalaki et al.
BRITISH JOURNAL OF CANCER (2009)
Angiogenic Balance in Pregnancy and Subsequent Breast Cancer Risk and Survival: A Population Study
Lars J. Vatten et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Placental ischemia and breast cancer risk after preeclampsia: tying the knot
Anne Gingery et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature
Eva-Maria Hedlund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The angiogenic switch in carcinogenesis
Vanessa Baeriswyl et al.
SEMINARS IN CANCER BIOLOGY (2009)
Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells
F. -C. Bidard et al.
ANNALS OF ONCOLOGY (2008)
Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during β cell carcinogenesis
Tibor Schomber et al.
CANCER RESEARCH (2007)
Anti-PIGF inhibits growth of VEGF(R)-Inhibitor-Resistant tumors without affecting healthy vessels
Christian Fischer et al.
CELL (2007)
Angiogenic factors and preeclampsia
May Lee Tjoa et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models
L Xu et al.
CANCER RESEARCH (2006)
Pro-angiogenic cytokines and their role in tumor angiogenesis
Gera Neufeld et al.
CANCER AND METASTASIS REVIEWS (2006)
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
Blockage of VEGF-induced angiogenesis by preventing VEGF secretion
M Björndahl et al.
CIRCULATION RESEARCH (2004)
Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers
A Eriksson et al.
CANCER CELL (2002)
Share Paper
